Business Context and Reporting Period
This Form 8-K is filed by Tharimmune, Inc. (not Canton Strategic Holdings, Inc.) for the reporting period of October 1, 2025. The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbol THAR. The filing reports the entry into a material definitive agreement regarding outstanding warrants.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a corporate action regarding equity instruments.
Material Changes
- Warrant Amendment: On October 1, 2025, the company entered into an amendment with holders of warrants to purchase an aggregate of 3,408,110 shares of common stock.
- Exercisability: The amendment makes these warrants immediately exercisable, removing any previous restrictions or vesting periods that may have applied.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies are detailed beyond the immediate impact of the warrant amendment. The filing does not disclose unusual items or non-recurring charges.
Investor Verification Checklist
- Verify the current share price to assess the immediate dilution impact of 3,408,110 shares becoming exercisable.
- Review the original warrant terms to understand the strike price and expiration date of the amended instruments.
- Confirm the company's current cash position to determine if it has sufficient liquidity to fund potential warrant exercises.
- Check for any subsequent filings regarding the actual exercise of these warrants.